{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:35:43Z","timestamp":1776821743854,"version":"3.51.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Clinical Key Specialty Construction Projec"},{"name":"Tianjin Key Medical Discipline (Specialty) Project","award":["TJYXZDXK-049A"],"award-info":[{"award-number":["TJYXZDXK-049A"]}]},{"name":"Tianjin Key Medical Discipline Project","award":["TJYXZDXK-3-032C"],"award-info":[{"award-number":["TJYXZDXK-3-032C"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04232-z","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:53:57Z","timestamp":1773460437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative CT assessment of structural and functional response to omalizumab in severe allergic asthma: a prospective real-world study"],"prefix":"10.1186","volume":"26","author":[{"given":"Shuang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuechuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"4232_CR1","unstructured":"2025 GINA strategy report. Global Initiative for Asthma - GINA. https:\/\/ginasthma.org\/2025-gina-strategy-report\/. Accessed 14 Jan 2026."},{"key":"4232_CR2","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nm.2678","volume":"18","author":"SE Wenzel","year":"2012","unstructured":"Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18:716\u201325. https:\/\/doi.org\/10.1038\/nm.2678.","journal-title":"Nat Med"},{"key":"4232_CR3","doi-asserted-by":"publisher","unstructured":"International, ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Kian Fan Chung, Wenzel SE, Brozek JL, Bush A, Castro M, Peter J, Sterk IM, Adcock ED, Bateman, Elisabeth H, Bel ER, Bleecker RL. Sorkness and W. Gerald Teague. Eur Respir J 2014; 43: 343\u2013373. Eur Respir J. 2018;52:1352020. https:\/\/doi.org\/10.1183\/13993003.52020-2013.","DOI":"10.1183\/13993003.52020-2013"},{"key":"4232_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2025.01.021","author":"N Deng","year":"2025","unstructured":"Deng N, Xianyu Y, Xu Y, Nie H. Small airways dysfunction in severe asthma: Current treatment approaches and future directions. J Formos Med Assoc. 2025. https:\/\/doi.org\/10.1016\/j.jfma.2025.01.021.","journal-title":"J Formos Med Assoc"},{"key":"4232_CR5","doi-asserted-by":"publisher","unstructured":"Paraskakis E, Sarikloglou E, Fouzas S, Steiropoulos P, Tsalkidis A, Bush A. Improved prediction of asthma exacerbations by measuring distal airway inflammation. Eur Respir J. 2022;60. https:\/\/doi.org\/10.1183\/13993003.01684-2021.","DOI":"10.1183\/13993003.01684-2021"},{"key":"4232_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jaci.2012.12.1567","volume":"131","author":"Small-airways dysfunction","year":"2013","unstructured":"Small-airways dysfunction. associates with respiratory symptoms and clinical features of asthma: A systematic review. J Allergy Clin Immunol. 2013;131:646\u201357. https:\/\/doi.org\/10.1016\/j.jaci.2012.12.1567.","journal-title":"J Allergy Clin Immunol"},{"key":"4232_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1378\/chest.10-1210","volume":"139","author":"Small Airway Disease in Asthma and COPD","year":"2011","unstructured":"Small Airway Disease in Asthma and COPD. Clinical Implications. Chest. 2011;139:412\u201323. https:\/\/doi.org\/10.1378\/chest.10-1210.","journal-title":"Chest"},{"key":"4232_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1365-2222.2005.02191.x","volume":"35","author":"ST Holgate","year":"2005","unstructured":"Holgate ST, Djukanovi\u0107 R, Casale T, Bousquet J. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy. Clin Exp Allergy. 2005;35:408\u201316. https:\/\/doi.org\/10.1111\/j.1365-2222.2005.02191.x.","journal-title":"Clin Exp Allergy"},{"key":"4232_CR9","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1016\/j.jaip.2021.01.011","volume":"9","author":"Real-World Effectiveness of Omalizumab in Severe Allergic Asthma","year":"2021","unstructured":"Real-World Effectiveness of Omalizumab in Severe Allergic Asthma. A Meta-Analysis of Observational Studies. J Allergy Clin Immunology: Pract. 2021;9:2702\u201314. https:\/\/doi.org\/10.1016\/j.jaip.2021.01.011.","journal-title":"J Allergy Clin Immunology: Pract"},{"key":"4232_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00408-011-9353-9","volume":"190","author":"OM Mets","year":"2012","unstructured":"Mets OM, de Jong PA, van Ginneken B, Gietema HA, Lammers JWJ. Quantitative Computed Tomography in COPD: Possibilities and Limitations. Lung. 2012;190:133\u201345. https:\/\/doi.org\/10.1007\/s00408-011-9353-9.","journal-title":"Lung"},{"key":"4232_CR11","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","volume":"187","author":"NA Hanania","year":"2013","unstructured":"Hanania NA, Wenzel S, Ros\u00e9n K, Hsieh H-J, Mosesova S, Choy DF, et al. Exploring the Effects of Omalizumab in Allergic Asthma. Am J Respir Crit Care Med. 2013;187:804\u201311. https:\/\/doi.org\/10.1164\/rccm.201208-1414OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"4232_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1398-9995.2004.00772.x","volume":"60","author":"M Humbert","year":"2005","unstructured":"Humbert M, Beasley R, Ayres JG, Slavin R, Herbert J. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inxadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy. 2005;60:309\u201316. https:\/\/doi.org\/10.1111\/j.1398-9995.2004.00772.x.","journal-title":"Allergy"},{"key":"4232_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S2213-2600(24)00362-X","volume":"13","author":"M Castro","year":"2025","unstructured":"Castro M, Papi A, Porsbjerg C, Lugogo NL, Brightling CE, Gonz\u00e1lez-Barcala F-J, et al. Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial. Lancet Respiratory Med. 2025;13:208\u201320. https:\/\/doi.org\/10.1016\/S2213-2600(24)00362-X.","journal-title":"Lancet Respiratory Med"},{"key":"4232_CR14","doi-asserted-by":"crossref","unstructured":"Menigoz C, Dirou S, Chambellan A, Hassoun D, Moui A, Magnan A et al. Use of FeNO to predict anti-IL-5 and IL-5R biologics efficacy in a real-world cohort of adults with severe eosinophilic asthma. J Asthma. 2023.","DOI":"10.2139\/ssrn.4046075"},{"key":"4232_CR15","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.clinthera.2019.07.021","volume":"41","author":"A Kavati","year":"2019","unstructured":"Kavati A, Zhdanava M, Ortiz B, Lecocq J, Schiffman B, Pilon D, et al. Retrospective Study on the Association of Biomarkers With Real-world Outcomes of Omalizumab-treated Patients With Allergic Asthma. Clin Ther. 2019;41:1956\u201371. https:\/\/doi.org\/10.1016\/j.clinthera.2019.07.021.","journal-title":"Clin Ther"},{"key":"4232_CR16","doi-asserted-by":"publisher","first-page":"113944","DOI":"10.1016\/j.bcp.2020.113944","volume":"179","author":"AN Frix","year":"2020","unstructured":"Frix AN, Schleich F, Paulus V, Guissard F, Henket M, Louis R. Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma. Biochem Pharmacol. 2020;179:113944. https:\/\/doi.org\/10.1016\/j.bcp.2020.113944.","journal-title":"Biochem Pharmacol"},{"key":"4232_CR17","doi-asserted-by":"publisher","unstructured":"Treb KJ, El Sadaney AO, Ferrero A, Baffour FI, Leng S, Yu L, et al. Quantitative CT imaging: where are we, and what is missing? Br J Radiol. 2025;tqaf075. https:\/\/doi.org\/10.1093\/bjr\/tqaf075.","DOI":"10.1093\/bjr\/tqaf075"},{"key":"4232_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43246-022-00259-x","volume":"3","author":"M Ge","year":"2022","unstructured":"Ge M, Huang X, Yan H, Gursoy D, Meng Y, Zhang J, et al. Three-dimensional imaging of grain boundaries via quantitative fluorescence X-ray tomography analysis. Commun Mater. 2022;3:1\u201311. https:\/\/doi.org\/10.1038\/s43246-022-00259-x.","journal-title":"Commun Mater"},{"key":"4232_CR19","doi-asserted-by":"publisher","first-page":"e0310892","DOI":"10.1371\/journal.pone.0310892","volume":"19","author":"FG Amorim","year":"2024","unstructured":"Amorim FG, dos Santos ER, Verrastro CGY, Kayser C. Quantitative chest computed tomography predicts mortality in systemic sclerosis: A longitudinal study. PLoS ONE. 2024;19:e0310892. https:\/\/doi.org\/10.1371\/journal.pone.0310892.","journal-title":"PLoS ONE"},{"key":"4232_CR20","doi-asserted-by":"publisher","first-page":"20170644","DOI":"10.1259\/bjr.20170644","volume":"91","author":"M Silva","year":"2018","unstructured":"Silva M, Milanese G, Seletti V, Ariani A, Sverzellati N. Pulmonary quantitative CT imaging in focal and diffuse disease: current research and clinical applications. Br J Radiol. 2018;91:20170644. https:\/\/doi.org\/10.1259\/bjr.20170644.","journal-title":"Br J Radiol"},{"key":"4232_CR21","doi-asserted-by":"publisher","first-page":"318029","DOI":"10.1155\/2010\/318029","volume":"17","author":"C Bergeron","year":"2010","unstructured":"Bergeron C, Tulic MK, Hamid Q. Airway Remodelling in Asthma: From Benchside to Clinical Practice. Can Respir J. 2010;17:318029. https:\/\/doi.org\/10.1155\/2010\/318029.","journal-title":"Can Respir J"},{"key":"4232_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.arbres.2024.09.007","volume":"61","author":"A Tiotiu","year":"2025","unstructured":"Tiotiu A, Steiropoulos P, Novakova S, Nedeva D, Novakova P, Chong-Neto H, et al. Airway Remodeling in Asthma: Mechanisms, Diagnosis, Treatment, and Future Directions. Arch Bronconeumol. 2025;61:31\u201340. https:\/\/doi.org\/10.1016\/j.arbres.2024.09.007.","journal-title":"Arch Bronconeumol"},{"key":"4232_CR23","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1056\/NEJMe1103121","volume":"364","author":"DJ Tschumperlin","year":"2011","unstructured":"Tschumperlin DJ. Physical Forces and Airway Remodeling in Asthma. N Engl J Med. 2011;364:2058\u20139. https:\/\/doi.org\/10.1056\/NEJMe1103121.","journal-title":"N Engl J Med"},{"key":"4232_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jaci.2005.07.011","volume":"116","author":"RM Pascual","year":"2005","unstructured":"Pascual RM, Peters SP. Airway remodeling contributes to the progressive loss of lung function in asthma: An overview. J Allergy Clin Immunol. 2005;116:477\u201386. https:\/\/doi.org\/10.1016\/j.jaci.2005.07.011.","journal-title":"J Allergy Clin Immunol"},{"key":"4232_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.mjafi.2021.01.018","volume":"78","author":"CDS Katoch","year":"2022","unstructured":"Katoch CDS, Vasan AS, Pathak K. Correlation of fraction of exhaled nitric oxide with asthma control test and asthma severity in diagnosed cases of asthma. Med J Armed Forces India. 2022;78:443\u20137. https:\/\/doi.org\/10.1016\/j.mjafi.2021.01.018.","journal-title":"Med J Armed Forces India"},{"key":"4232_CR26","doi-asserted-by":"publisher","unstructured":"Afriyie-Mensah JS, Domoyeri,Philemon A-B et al. Charles, Aryee, Robert, Dankwah, Gifty B., Ntiamoah, Mabel,. Relationship between fraction of exhaled nitric oxide and peripheral eosinophilia in asthma. Ann Med. 2024;56:2382377. https:\/\/doi.org\/10.1080\/07853890.2024.2382377.","DOI":"10.1080\/07853890.2024.2382377"},{"key":"4232_CR27","doi-asserted-by":"publisher","unstructured":"Gao Y, Li Z, Wu N, Jiang C, Liu Y, Zhou S et al. The change of FeNO is correlated with asthma control and lung function. Heliyon. 2024;10. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38875.","DOI":"10.1016\/j.heliyon.2024.e38875"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04232-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04232-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04232-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:38:51Z","timestamp":1776818331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04232-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4232"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04232-z","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The research protocol was approved by the Ethics Committee of Tianjin Chest Hospital, Tianjin University (Approval No. 2024LW-009). Written informed consent was obtained from all participants prior to enrollment. All participants provided written informed consent for participation in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}